A recent study demonstrated that over 94% of colorectal cancers had a mutation in the Wnt/β-catenin signaling pathway [34], resulting in the accumulation of β-catenin and increased activity of c-myc [35]. This evidence concerns the gene MYC and colorectal cancer.